ResMed Inc. (ASX: RMD) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
ResMed Inc. Chart and Price Data
Fundamentals Data provided by Morningstar.
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
ResMed Inc. (ASX: RMD)
Latest News
How to invest
How to stay calm and profit from an ASX share market crash
Blue Chip Shares
5 reasons to buy and hold this Australian stock forever
Healthcare Shares
Four healthcare stocks Wilsons Advisory says are worth a look
Broker Notes
In a frothy market, here are five stocks one broker says still represent good value
Growth Shares
Here are the 3 Australian stocks I'd tell a new investor to buy ASAP
Broker Notes
Buy, hold, sell: ResMed, Sonic Healthcare, and Steadfast
Broker Notes
Buy this ASX ETF and hold this popular blue chip ASX 200 share
How to invest
The easy way to build a $30,000 a year passive income
Growth Shares
The 2 Australian stocks I'd hold forever
Share Market News
How much superannuation at 40 is enough to retire a millionaire?
How to invest
How to build generational wealth with ASX shares
Dividend Investing
How much passive income $200,000 in ASX shares could deliver
Frequently Asked Questions
-
Yes. As well as being listed on the ASX since November 1999, ResMed trades on the New York Stock Exchange under the ticker code NYSE: RMD.
-
Yes, historically ResMed pays unfranked quarterly dividends each year. It does not offer a dividend reinvestment plan.
RMD ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About ResMed Inc.
ResMed Inc (ASX: RMD) is a global leader in sleep technology. It develops, manufactures, and distributes medical devices – such as flow generators, CPAP masks, and accessories – and cloud-based software applications that diagnose, treat, and manage a range of respiratory disorders including sleep apnea, chronic obstructive pulmonary disease (COPD), and neuromuscular disease.
It also provides software platforms to support professionals and caregivers to help patients in an out-of-hospital setting. The company operates in more than 140 countries, with manufacturing facilities in Australia, Singapore, France, and the United States. ResMed was established in Australia in 1989 but is now based in San Diego in the United States.
